Cancers sustaining homozygous MTAP deletions are thus expected to accumulate MTA; extensive in vitro evidence in diverse cancer cell lines supports this logic9,10 (though methionine and cysteine availability in media also influences MTA levels11). This evidence concerns the gene MTAP and cancer.